相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alternative polyadenylation of mRNA and its role in cancer
Fuwen Yuan et al.
GENES & DISEASES (2021)
Requirement for cleavage factor IIm in the control of alternative polyadenylation in breast cancer cells
Rachael E. Turner et al.
RNA (2020)
Emerging Roles of RNA 3′-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders
Jamie Nourse et al.
BIOMOLECULES (2020)
Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT
Qian Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
Arian Lundberg et al.
BREAST CANCER RESEARCH (2019)
Molecular basis for the recognition of the human AAUAAA polyadenylation signal
Yadong Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cell Cycle Regulation by Alternative Polyadenylation of CCND1
Qiong Wang et al.
SCIENTIFIC REPORTS (2018)
CSTF2-Induced Shortening of the RAC1 3 ' UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder
Xin Chen et al.
CANCER RESEARCH (2018)
Transcriptome 3′ end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma
Anton Ogorodnikov et al.
NATURE COMMUNICATIONS (2018)
c Alternative polyadenylation factors link cell cycle to migration
Mithun Mitra et al.
GENOME BIOLOGY (2018)
The contribution of alternative polyadenylation to the cancer phenotype
Chioniso P. Masamha et al.
CARCINOGENESIS (2018)
Short poly(A) tails are a conserved feature of highly expressed genes
Sarah Azoubel Lima et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases
Weimin Li et al.
NUCLEIC ACIDS RESEARCH (2017)
Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma
Angela B. Ortiz et al.
PLOS ONE (2017)
Short poly(A) tails are a conserved feature of highly expressed genes
Sarah Azoubel Lima et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target Role of CPSF6 in Breast Cancer
Najat Binothman et al.
EBIOMEDICINE (2017)
Treating cancer with selective CDK4/6 inhibitors
Ben O'Leary et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The 3′UTR signature defines a highly metastatic subgroup of triple-negative breast cancer
Lei Wang et al.
ONCOTARGET (2016)
Systematic analysis of the contribution of c-myc mRNA constituents upon cap and IRES mediated translation
Christos Meristoudis et al.
BIOLOGICAL CHEMISTRY (2015)
Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer
Soo Youn Bae et al.
BMC CANCER (2015)
3′UTR shortening and EGF signaling: implications for breast cancer
Hesna Begum Akman et al.
HUMAN MOLECULAR GENETICS (2015)
Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance
Hao-Ting Sun et al.
ONCOTARGETS AND THERAPY (2015)
Systematic Profiling of Poly(A) plus Transcripts Modulated by Core 3′ End Processing and Splicing Factors Reveals Regulatory Rules of Alternative Cleavage and Polyadenylation
Wencheng Li et al.
PLOS GENETICS (2015)
Fip1 regulates mRNA alternative polyadenylation to promote stem cell self-renewal
Brad Lackford et al.
EMBO JOURNAL (2014)
Poly(A) polymerase (PAP) diversity in gene expression - Star-PAP vs canonical PAP
Rakesh S. Laishram
FEBS LETTERS (2014)
Reconstitution of CPSF active in polyadenylation: recognition of the polyadenylation signal by WDR33
Lars Schoenemann et al.
GENES & DEVELOPMENT (2014)
CFIm25 links alternative polyadenylation to glioblastoma tumour suppression
Chioniso P. Masamha et al.
NATURE (2014)
Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′- UTR landscape across seven tumour types
Zheng Xia et al.
NATURE COMMUNICATIONS (2014)
RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial
Dana Keilty et al.
PLOS ONE (2013)
GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients
Mary Anne Quintayo et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A quantitative atlas of polyadenylation in five mammals
Adnan Derti et al.
GENOME RESEARCH (2012)
Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation
Eleonora de Klerk et al.
NUCLEIC ACIDS RESEARCH (2012)
Inhibition of polyadenylation reduces inflammatory gene induction
Alexander Kondrashov et al.
RNA (2012)
ePAT: A simple method to tag adenylated RNA to measure poly(A)-tail length and other 3′ RACE applications
Amrei Jaenicke et al.
RNA (2012)
Genome-wide Analysis of Pre-mRNA 3′ End Processing Reveals a Decisive Role of Human Cleavage Factor I in the Regulation of 3′ UTR Length
Georges Martin et al.
CELL REPORTS (2012)
E2F mediates enhanced alternative polyadenylation in proliferation
Ran Elkon et al.
GENOME BIOLOGY (2012)
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study
Katja Lundgren et al.
BREAST CANCER RESEARCH (2012)
Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model
Min Wei et al.
CANCER SCIENCE (2011)
Differential genome-wide profiling of tandem 3′ UTRs among human breast cancer and normal cells by high-throughput sequencing
Yonggui Fu et al.
GENOME RESEARCH (2011)
Mechanisms and Consequences of Alternative Polyadenylation
Dafne Campigli Di Giammartino et al.
MOLECULAR CELL (2011)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
The structure of the 5'-untranslated region of mammalian poly(A) polymerase-α mRNA suggests a mechanism of translational regulation
Aikaterini Rapti et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation
Daisuke Kaida et al.
NATURE (2010)
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen
Frederic Bienvenu et al.
NATURE (2010)
Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation
Stefania Millevoi et al.
NUCLEIC ACIDS RESEARCH (2010)
EPIGENETICS AND GENETICS A census of amplified and overexpressed human cancer genes
Thomas Santarius et al.
NATURE REVIEWS CANCER (2010)
MCF-7 breast carcinoma cells do not express caspase-3
Reiner U. Jaenicke
BREAST CANCER RESEARCH AND TREATMENT (2009)
Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
Christine Mayr et al.
CELL (2009)
3′UTR mediated regulation of the cyclin D1 proto-oncogene
Anagha Deshpande et al.
CELL CYCLE (2009)
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
Carey K. Anders et al.
CLINICAL BREAST CANCER (2009)
Anchorage-independent cell growth signature identifies tumors with metastatic potential
S. Mori et al.
ONCOGENE (2009)
Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types
Zhe Ji et al.
PLOS ONE (2009)
Twenty-five years of quantitative PCR for gene expression analysis
Heather D. VanGuilder et al.
BIOTECHNIQUES (2008)
Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites
Rickard Sandberg et al.
SCIENCE (2008)
Widespread use of poly(A) tail length control to accentuate expression of the yeast transcriptome
Traude H. Beilharz et al.
RNA (2007)
Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression
Etsu Tashiro et al.
CANCER SCIENCE (2007)
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
Adrian Wiestner et al.
BLOOD (2007)
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression
M Grillo et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1
B Sander et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
XJ Cui et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclin D1 in breast cancer pathogenesis
A Arnold et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A large-scale analysis of mRNA polyadenylation of human and mouse genes
B Tian et al.
NUCLEIC ACIDS RESEARCH (2005)
Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase
I Kaufmann et al.
EMBO JOURNAL (2004)
Living with or without cyclins and cyclin-dependent kinases
CJ Sherr et al.
GENES & DEVELOPMENT (2004)
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
VJ Bardou et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer
L Nakopoulou et al.
MODERN PATHOLOGY (2002)
Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models
RL Sutherland et al.
BREAST CANCER RESEARCH (2002)
Identification and functional characterization of neo-poly(A) polymerase, an RNA processing enzyme overexpressed in human tumors
SL Topalian et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
